Quantification of the amounts of total tau (t-tau) and phosphorylated tau (p-tau) have been found to correlate with loss of cognition and with neurodegeneration in autopsied AD patients [2,3] and in antemortem CSF [4]. The gene discussed is MAPT; the disease is Alzheimer disease.